United States Vaccines Market Overview
Base Year: 2023
Historical Years: 2018-2023
Forecast Years: 2024-2032
Market Growth Rate: 5.91% (2024-2032)
Growth in the U.S. vaccine industry is steady. Strong healthcare infrastructure and ongoing innovation support this progress. Increased awareness and related government initiatives propel further market development. According to the latest report by IMARC Group, the United States vaccines market size is projected to exhibit a growth rate (CAGR) of 5.91% during 2024-2032.
Download a sample copy of the Report: https://www.imarcgroup.com/united-states-vaccines-market/requestsample
United States Vaccines Industry Trends and Drivers:
The US vaccine market is growing quickly. This growth comes from advances in biotechnology. It also stems from a stronger focus on preventive healthcare. The COVID-19 pandemic may have played a role, too. Researchers group vaccines for diseases like influenza and HPV with new threats. These include RSV and possible future pandemics. Pharmaceutical companies are making large investments in research and development. This funding is creating new vaccine technologies. One example is the mRNA platform, which gained fame during the COVID-19 pandemic. Other initiatives, like the CDC's Vaccines for Children (VFC) program, boost market growth. Also, more federal funding for vaccine development helps too. Vaccine hesitancy, distribution issues, and high production costs hold back these benefits. Combination vaccines are now emerging in the market. Patients get one shot that protects against several diseases, but they need a few shots for each one. This increases patient compliance and lowers healthcare costs.
A major shift in the U.S. vaccine market is the focus on adult and elderly vaccination programs. This change is due to the increasing aging population and more age-related diseases. More older adults are getting shingles, pneumococcal, and COVID-19 booster vaccines. Some private efforts aim for easy access to testing. For example, CVS and Walgreens provide pharmacy services for those in need. Digital health tools are important. Vaccine apps that track data and AI tools predict crowd movement. They aid in public health efforts and outreach. The market is getting more competitive. Smaller biotech companies are now competing with bigger, established players. They are finding success by focusing on niche markets. The United States is a leader in vaccine innovation. However, cooperation and equity initiatives are now making progress. These efforts aim to tackle the vaccine access issues in low-income countries.
We explore the factors propelling the United States vaccines market growth, including technological advancements, consumer behaviors, and regulatory changes.
United States Vaccines Industry Segmentation:
The report has segmented the market into the following categories:
Technology Insights:
- Conjugate Vaccines
- Inactivated and Subunit Vaccines
- Live Attenuated Vaccines
- Recombinant Vaccines
- Toxoid Vaccines
- Others
Patient Type Insights:
- Pediatric
- Adult
Indication Insights:
- Bacterial Diseases
- Meningococcal Disease
- Pneumococcal Disease
- Diphtheria/Tetanus/Pertussis (DPT)
- Tuberculosis
- Haemophilus Influenzae (Hib)
- Typhoid
- Others
- Viral Diseases
- Hepatitis
- Influenza
- Human Papillomavirus (HPV)
- Measles/Mumps/Rubella (MMR)
- Rotavirus
- Herpes Zoster
- Varicella
- Japanese Encephalitis
- Rubella
- Polio
- Rabies
- Dengue
- Others
Route of Administration Insights:
- Intramuscular and Subcutaneous Administration
- Oral Administration
- Others
Product Type Insights:
- Multivalent Vaccine
- Monovalent Vaccine
Treatment Type Insights:
- Preventive Vaccine
- Therapeutic Vaccine
End User Insights:
- Hospitals
- Clinics
- Vaccination Centers
- Academic and Research Institutes
- Others
Distribution Channel Insights:
- Hospital Pharmacies
- Retail Pharmacies
- Institutional Sales
- Others
Regional Insights:
- Northeast
- Midwest
- South
- West
Competitive Landscape:
The competitive landscape of the industry has also been examined, along with the profiles of the key players.
Key highlights of the Report:
- Market Performance (2018-2023)
- Market Outlook (2024-2032)
- COVID-19 Impact on the Market
- Porter’s Five Forces Analysis
- Strategic Recommendations
- Historical, Current, and Future Market Trends
- Market Drivers and Success Factors
- SWOT Analysis
- Structure of the Market
- Value Chain Analysis
- Comprehensive Mapping of the Competitive Landscape
Note: If you need specific information that is not currently within the scope of the report, we can provide it to you as a part of the customization.
About Us:
IMARC Group is a global management consulting firm that helps the world’s most ambitious changemakers to create a lasting impact. The company provides a comprehensive suite of market entry and expansion services. IMARC offerings include a thorough market assessment, feasibility studies, company incorporation assistance, factory setup support, regulatory approvals and licensing navigation, branding, marketing and sales strategies, competitive landscape, and benchmarking analyses, pricing and cost research, and procurement research.
Contact Us:
IMARC Group
134 N 4th St. Brooklyn, NY 11249, USA
Email: [email protected]
Tel No:(D) +91 120 433 0800
United States: +1-631-791-1145
